MedTrace Logo

Evaluation of the Efficacy and Tolerability of ABO/MEG-B-09 in Children With Acute Cough

NCT01259674 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2014-12-02

No results posted yet for this study

Summary

The present clinical trial will examine the use of ABO/MEG-B-09 syrup in children with acute cough as compared to a placebo syrup.

Conditions

Interventions

DEVICE

AboMeg-B-09

Syrup: AboMeg-B-09 5ml to be taken 4 times a day during the entire study period

OTHER

Placebo

Placebo syrup: 5ml to be taken 4 times a day during the entire study period

Sponsors & Collaborators

  • Sprim Advanced Life Sciences

    collaborator OTHER

  • Aboca Spa Societa' Agricola

    lead INDUSTRY

Principal Investigators

  • Arienne de Jong, PhD · Sprim Advanced Life Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01259674 on ClinicalTrials.gov